186 related articles for article (PubMed ID: 1547980)
1. [The rhesus problem today].
Schneider J; Behrens O
Gynakologe; 1992 Feb; 25(1):36-40. PubMed ID: 1547980
[No Abstract] [Full Text] [Related]
2. [Current viewpoints in the anti-D prevention of rhesus alloimmunization in the pregnant woman and of hemolytic disease of the newborn infant (a review of the literature)].
Spasova K; Vŭlcheva B
Akush Ginekol (Sofiia); 1986; 25(3):84-90. PubMed ID: 3019168
[No Abstract] [Full Text] [Related]
3. Ten-year experience with high titer anti-D plasma for the prevention of Rh isoimmunization.
Hamilton EG
Obstet Gynecol; 1972 Nov; 40(5):692-6. PubMed ID: 4628388
[No Abstract] [Full Text] [Related]
4. [Actual possibilities of prevention of serologic incompatibility].
Breborowicz H; Gerwelowa H; Krawczyńska Z; Baraniecka K; Gruszczyńska J; Karowa L
Pol Tyg Lek; 1968 Sep; 23(35):1305-7. PubMed ID: 4972438
[No Abstract] [Full Text] [Related]
5. Rhesus iso-immunization prevention program: a nursing alert.
Field PA; Boyd J
AARN News Lett; 1976 Mar; 32(3):1-2. PubMed ID: 816166
[No Abstract] [Full Text] [Related]
6. Rhesus and other blood group incompatibilities in pregnancy.
Gunston KD; Botha I
S Afr Med J; 1980 Oct; 58(16):639-41. PubMed ID: 6775377
[TBL] [Abstract][Full Text] [Related]
7. [Practical problems in prevention of Rh-sensitization with immunological methods].
Althoff W; Schellong G; Stahl M
Minerva Med; 1969 Jul; 60(59):2905-15. PubMed ID: 4978556
[No Abstract] [Full Text] [Related]
8. [Prevention of fetal erythroblastosis with anti-D immunoglobulin].
Rasteński J; Gryglicka M
Acta Haematol Pol; 1988; 19(3-4):239-41. PubMed ID: 3150900
[No Abstract] [Full Text] [Related]
9. [10 years of specific prophylaxis of hemolytic disease of the newborn in Bulgaria].
Kurteva B; Doĭchinova N; Shinkov D; Angelova Ts; Ivanova L
Akush Ginekol (Sofiia); 1979; 18(3):172-9. PubMed ID: 89820
[No Abstract] [Full Text] [Related]
10. Economics of anti-rhesus prophylaxis in an African population.
Verkuyl DA
Cent Afr J Med; 1987 Feb; 33(2):32-7. PubMed ID: 3121186
[No Abstract] [Full Text] [Related]
11. [Rhesus immunoprevention by means of immunoglobulin anti-D].
Maas DH; Schneider
Med Monatsschr; 1975 Aug; 29(8):340-7. PubMed ID: 813106
[No Abstract] [Full Text] [Related]
12. Do we need to be more concerned about weak D antigens?
Garratty G
Transfusion; 2005 Oct; 45(10):1547-51. PubMed ID: 16181202
[No Abstract] [Full Text] [Related]
13. [Different aspects of using antirhesus immunoglobulin].
Belozerova VI
Probl Gematol Pereliv Krovi; 1979 Oct; 24(10):49-54. PubMed ID: 92019
[No Abstract] [Full Text] [Related]
14. Rhesus and other antibodies.
O'Sullivan JF
Clin Obstet Gynaecol; 1982 Apr; 9(1):91-9. PubMed ID: 6809392
[No Abstract] [Full Text] [Related]
15. Recent understanding for the mechanism by which passively administered Rh antibody suppresses the immune response to Rh antigen in unimmunized Rh-negative women.
Pollack W
Clin Obstet Gynecol; 1982 Jun; 25(2):255-65. PubMed ID: 6809384
[No Abstract] [Full Text] [Related]
16. Editorial: Prevention of rhesus immunization in Australia.
Med J Aust; 1975 Aug; 2(7):241. PubMed ID: 808696
[No Abstract] [Full Text] [Related]
17. [Problems in anti-rhesus (D) immunoprophylaxis].
Bennebroek Gravenhorst J; Overbeeke MA; van Dijk BA
Ned Tijdschr Geneeskd; 1984 May; 128(21):1005-9. PubMed ID: 6429554
[No Abstract] [Full Text] [Related]
18. [Modern trends in prevention of anti-Rh immunization].
Malaguzzi Valeri O
Minerva Med; 1969 Apr; 60(31):1503-4. PubMed ID: 4977456
[No Abstract] [Full Text] [Related]
19. [Hemolytic disease of the newborn caused by rarely occurring antibodies to various blood group systems].
Maszkiewicz W; Ornat K; Zarczyńska B; Bagińska T; Irzyńska D
Acta Haematol Pol; 1988; 19(1-2):77-80. PubMed ID: 3149115
[No Abstract] [Full Text] [Related]
20. The introduction of human monoclonal anti-D for therapeutic use.
Fletcher A; Thomson A
Transfus Med Rev; 1995 Oct; 9(4):314-26. PubMed ID: 8541714
[No Abstract] [Full Text] [Related]
[Next] [New Search]
